［1］ MORICE M C，SERRUYS P W，SOUSA J E，et al.A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization［J］.N Engl J Med，2002，346（23）：1773-1780.

［2］ SERRUYS P W，RUYGROK P，NEUZNER J，et al.A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent：the SPIRIT Ⅱtrial［J］.EuroIntervention，2006，2（3）：286-294.

［3］ ONUMA Y，MIQUEL-HEBERT K，SERRUYS P W.Five-year long-term clinical followup of the XIENCE Ⅴ everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery disease：the SPIRIT Ⅱ trial［J］.EuroIntervention，2013，8（9）：1047-1051.

［4］ GADA H，KIRTANE A J，NEWMAN W，et al.5-year results of a randomized comparison of XIENCE Ⅴ everolimus-eluting and TAXUS paclitaxel-eluting stents：final results from the SPIRIT Ⅲ trial（clinical evaluation of the XIENCE Ⅴ everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions）［J］.JACC Cardiovasc Interv，2013，6（12）：1263-1266.

［5］ MEHRAN R，DANGAS G，ABIZAID A S，et al.Angiographic patterns of in-stent restenosis：classification and implications for long-term outcome［J］.Circulation，1999，100（18）：1872-1878.

［6］ ABIZAID A，KORNOWSKI R，MINTZ G S，et al.The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation［J］.J Am Coll Cardiol，1998，32（3）：584-589.

［7］ LEE S G，LEE C W，HONG M K，et al.Predictors of diffuse-type in-stent restenosis after coronary stent implantation［J］.Catheter Cardiovasc Interv，1999，47（4）：406-409.

［8］ KASTRATI A，ELEZI S，DIRSCHINGER J，et al.Influence of lesion length on restenosis after coronary stent placement［J］.Am J Cardiol，1999，83（12）：1617-1622.

［9］ KOBAYASHI Y，DE GREGORIO J，KOBAYASHI N，et al.Stented segment length as an independent predictor of restenosis［J］.J Am Coll Cardiol，1999，34（3）：651-659.

［10］ KASTRATI A，MEHILLI J，DIRSCHINGER J，et al.Intracoronary stenting and angiographic results：strut thickness effect on restenosis outcome（ISAR-STEREO） trial［J］.Circulation，2001，103（23）：2816-2821.

［11］ MINTZ G S，WEISSMAN N J.Intravascular ultrasound in the drug-eluting stent era［J］.J Am Coll Cardiol，2006，48（3）：421-429.

［12］ ESCANED J，GOICOLEA J，ALFONSO F，et al.Propensity and mechanisms of restenosis in different coronary stent designs：complementary value of the analysis of the luminal gain-loss relationship［J］.J Am Coll Cardiol，1999，34（5）：1490-1497.

［13］ HOFFMANN R，MINTZ G S，MEHRAN R，et al.Intravascular ultrasound predictors of angiographic restenosis in lesions treated with Palmaz-Schatz stents［J］.J Am Coll Cardiol，1998，31（1）：43-49.

［14］ SAHARA M，KIRIGAYA H，OIKAWA Y，et al.Soft plaque detected on intravascular ultrasound is the strongest predictor of in-stent restenosis：an intravascular ultrasound study［J］.Eur Heart J，2004，25（22）：2026-2033.

［15］ DANGAS G D，CLAESSEN B E，CAIXETA A，et al.In-stent restenosis in the drugeluting stent era［J］.J Am Coll Cardiol，2010，56（23）：1897-1907.

［16］ MEHRAN R，MINTZ G S，POPMA J J，et al.Mechanisms and results of balloon angioplasty for the treatment of in-stent restenosis［J］.Am J Cardiol，1996，78（6）：618-622.

［17］ BAUTERS C，BANOS J L，VAN BELLE E，et al.Six-month angiographic outcome after successful repeat percutaneous intervention for in-stent restenosis［J］.Circulation，1998，97（4）：318-321.

［18］ ALBIERO R，SILBER S，DI MARIO C，et al.Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis：results of the restenosis cutting balloon evaluation trial（RESCUT）［J］.J Am Coll Cardiol，2004，43（6）：943-949.

［19］ ELTCHANINOFF H，KONING R，TRON C，et al.Balloon angioplasty for the treatment of coronary in-stent restenosis：immediate results and 6-month angiographic recurrent restenosis rate［J］.J Am Coll Cardiol，1998，32（4）：980-984.

［20］ SHIRAN A，MINTZ G S，WAKSMAN R，et al.Early lumen loss after treatment of instent restenosis：an intravascular ultrasound study［J］.Circulation，1998，98（3）：200-203.

［21］ SHARMA S K，KINI A，MEHRAN R，et al.Randomized trial of Rotational Atherectomy Versus Balloon Angioplasty for Diffuse In-stent Restenosis（ROSTER）［J］.Am Heart J，2004，147（1）：16-22.

［22］ MEHRAN R，DANGAS G，MINTZ G S，et al.Treatment of in-stent restenosis with excimer laser coronary angioplasty versus rotational atherectomy：comparative mechanisms and results［J］.Circulation，2000，101（21）：2484-2489.

［23］ KÖSTER R，HAMM C W，SEABRA-GOMES R，et al.Laser angioplasty of restenosed coronary stents：results of a multicenter surveillance trial.The Laser Angioplasty of Restenosed Stents（LARS） Investigators［J］.J Am Coll Cardiol，1999，34（1）：25-32.

［24］ ALFONSO F，CEQUIER A，ZUECO J，et al.Stenting the stent：initial results and longterm clinical and angiographic outcome of coronary stenting for patients with in-stent restenosis［J］.Am J Cardiol，2000，85（3）：327-332.

［25］ MEHRAN R，DANGAS G，ABIZAID A，et al.Treatment of focal in-stent restenosis with balloon angioplasty alone versus stenting：Short-and long-term results［J］.Am Heart J，2001，141（4）：610-614.

［26］ ALFONSO F，ZUECO J，CEQUIER A，et al.A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis［J］.J Am Coll Cardiol，2003，42（5）：796-805.

［27］ SOUSA J E，COSTA M A，ABIZAID A，et al.Sirolimus-eluting stent for the treatment of in-stent restenosis：a quantitative coronary angiography and three-dimensional intravascular ultrasound study［J］.Circulation，2003，107（1）：24-27.

［28］ DEGERTEKIN M，REGAR E，TANABE K，et al.Sirolimus-eluting stent for treatment of complex in-stent restenosis：the first clinical experience［J］.J Am Coll Cardiol，2003，41（2）：184-189.

［29］ SAIA F，LEMOS P A，SIANOS G，et al.Effectiveness of sirolimus-eluting stent implantation for recurrent in-stent restenosis after brachytherapy［J］.Am J Cardiol，2003，92（2）：200-203.

［30］ MÖLLMANN H，ELSÄSSER A，NEF H，et al.Treatment of in-stent restenosis with sirolimus-eluting-stents：results from the prospective German Cypher stent registry［J］.Clin Res Cardiol，2008，97（7）：432-440.

［31］ LIISTRO F，FINESCHI M，GROTTI S，et al.Long-term effectiveness and safety of sirolimus stent implantation for coronary in-stent restenosis results of the TRUE（Tuscany Registry of sirolimus for unselected in-stent restenosis） registry at 4 years［J］.J Am Coll Cardiol，2010，55（7）：613-616.

［32］ KASTRATI A，MEHILLI J，VON BECKERATH N，et al.Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis：a randomized controlled trial［J］.JAMA，2005，293（2）：165-171.

［33］ ALFONSO F，PÉREZ-VIZCAYNO M J，HERNANDEZ R，et al.A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis：results of the Restenosis Intrastent：Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting（RIBS-Ⅱ） trial［J］.J Am Coll Cardiol，2006，47（11）：2152-2160.

［34］ SINGH I M，FILBY S J，SAKR F E，et al.Clinical outcomes of drug-eluting versus baremetal in-stent restenosis［J］.Catheter Cardiovasc Interv，2010，75（3）：338-342.

［35］ NEUMANN F J，DESMET W，GRUBE E，et al.Effectiveness and safety of sirolimuseluting stents in the treatment of restenosis after coronary stent placement［J］.Circulation，2005，111（16）：2107-2111.

［36］ SOUSA J E，SERRUYS P W，Costa M A.New frontiers in cardiology：drug-eluting stents：Part Ⅱ［J］.Circulation，2003，107（18）：2383-2389.

［37］ WAKSMAN R，WHITE R L，CHAN R C，et al.Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis［J］.Circulation，2000，101（18）：2165-2171.

［38］ WAKSMAN R，AJANI A E，WHITE R L，et al.Intravascular gamma radiation for instent restenosis in saphenous-vein bypass grafts［J］.N Engl J Med，2002，346（16）：1194-1199.

［39］ WAKSMAN R，CHENEAU E，AJANI A E，et al.Intracoronary radiation therapy improves the clinical and angiographic outcomes of diffuse in-stent restenotic lesions：results of the Washington Radiation for In-Stent Restenosis Trial for Long Lesions（Long WRIST） Studies［J］.Circulation，2003，107（13）：1744-1749.

［40］ LEON M B，TEIRSTEIN P S，MOSES J W，et al.Localized intracoronary gammaradiation therapy to inhibit the recurrence of restenosis after stenting［J］.N Engl J Med，2001，344（4）：250-256.

［41］ WAKSMAN R，AJANI A E，WHITE R L，et al.Five-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis［J］.Circulation，2004，109（3）：340-344.

［42］ WAKSMAN R，BHARGAVA B，WHITE L，et al.Intracoronary beta-radiation therapy inhibits recurrence of in-stent restenosis［J］.Circulation，2000，101（16）：1895-1898.

［43］ POPMA J J，SUNTHARALINGAM M，LANSKY A J，et al.Randomized trial of ⁹⁰Sr/ ⁹⁰Y beta-radiation versus placebo control for treatment of in-stent restenosis［J］.Circulation，2002，106（9）：1090-1096.

［44］ WAKSMAN R，RAIZNER A E，YEUNG A C，et al.Use of localised intracoronary beta radiation in treatment of in-stent restenosis：the INHIBIT randomised controlled trial［J］.Lancet，2002，359（9306）：551-557.

［45］ HOLMES D R Jr，TEIRSTEIN P，SATLER L，et al.Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents：the SISR randomized trial［J］.JAMA，2006，295（11）：1264-1273.

［46］ STONE G W，ELLIS S G，O’SHAUGHNESSY C D，et al.Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents：the TAXUSⅤ ISR randomized trial［J］.JAMA，2006，295（11）：1253-1263.

［47］ ELLIS S G，O’SHAUGHNESSY C D，MARTIN S L，et al.Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis：the TAXUS Ⅴ ISR trial［J］.Eur Heart J，2008，29（13）：1625-1634.

［48］ DIBRA A，KASTRATI A，ALFONSO F，et al.Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis：meta-analysis of randomized trials［J］.J Am Coll Cardiol，2007，49（5）：616-623.

［49］ Acute platelet inhibition with abciximab does not reduce in-stent restenosis（ERASER study）.The ERASER Investigators［J］.Circulation，1999，100（8）：799-806.

［50］ STOJKOVIC S，OSTOJIC M，NEDELJKOVIC M，et al.Systemic rapamycin without loading dose for restenosis prevention after coronary bare metal stent implantation［J］.Catheter Cardiovasc Interv，2010，75（3）：317-325.

［51］ ALFONSO F，PÉREZ-VIZCAYNO M J，CÁRDENAS A，et al.A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stentin-stent restenosis：the RIBSⅤ Clinical Trial（Restenosis Intra-stent of Bare Metal Stents：paclitaxel-eluting balloon vs.everolimus-eluting stent）［J］.J Am Coll Cardiol，2014，63（14）：1378-1386.

［52］ XU B，GAO R，WANG J，et al.A prospective，multicenter，randomized trial of paclitaxelcoated balloon versus paclitaxel-eluting stent for the treatment of drug-eluting stent instent restenosis：results from the PEPCAD China ISR trial［J］.JACC Cardiovasc Interv，2014，7（2）：204-211.

［53］ AGOSTONI P，BELKACEMI A，VOSKUIL M，et al.Serial morphological and functional assessment of drug-eluting balloon for in-stent restenotic lesions：mechanisms of action evaluated with angiography，optical coherence tomography，and fractional flow reserve［J］.JACC Cardiovasc Interv，2013，6（6）：569-576.

［54］ SCHELLER B，HEHRLEIN C，BOCKSCH W，et al.Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter［J］.N Engl J Med，2006，355（20）：2113-2124.

［55］ SCHELLER B，HEHRLEIN C，BOCKSCH W，et al.Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon cathe ter［J］.Clin Res Cardiol，2008，97（10）：773-781.

［56］ SCHELLER B，CLEVER Y P，KELSCH B，et al.Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter［J］.JACC Cardiovasc Interv，2012，5（3）：323-330.

［57］ UNVERDORBEN M，VALLBRACHT C，CREMERS B，et al.Paclitaxel-coated balloon catheter ver sus paclitaxel-coated stent for the treatment of coronary in-stent restenosis ［J］.Circulation，2009，119（23）：2986-2994.

［58］ RITTGER H，BRACHMANN J，SINHA A M，et al.A randomized，multicenter，singleblinded trial comparing paclitaxel-coated balloon angioplasty with plain bal loon angioplasty in drug-eluting stent restenosis：the PEPCAD-DES study［J］.J Am Coll Cardiol，2012，59（15）：1377-1382.

［59］ HABARA S，MITSUDO K，KADOTA K，et al.Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis［J］.JACC Cardiovasc Interv，2011，4（2）：149-154.

［60］ BYRNE R A，NEUMANN F J，MEHILLI J，et al.Paclitaxel-eluting balloons，paclitaxeleluting stents，and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent（ISAR-DESIRE 3）：a ran domised，open-label trial［J］.Lancet，2013，381（9865）：461-467.

［61］ WÖHRLE J，ZADURA M，MÖBIUS-WINKLER S，et al.SeQuent Please World Wide Registry：clinical results of SeQuent Please paclitaxel-coated balloon angioplasty in a large-scale，pro spective registry study［J］.J Am Coll Cardiol，2012，60（18）：1733-1738.

［62］ VAQUERIZO B，SERRA A，MIRANDA-GUARDIOLA F，et al.One-year outcomes with angiographic follow-up of paclitaxel-eluting balloon for the treatment of in-stent restenosis：insights from Spanish multicenter registry［J］.J Interv Cardiol，2011，24（6）：518-528.

［63］ STELLA P R，BELKACEMI A，WAKSMAN R，et al.The Valentines Trial：results of the first one week worldwide multicentre enrolment trial，evaluating the real world usage of the second generation DIOR paclitaxel drug-eluting bal loon for in-stent restenosis treatment［J］.EuroIntervention，2011，7（6）：705-710.

［64］ HEHRLEIN C，DIETZ U，KUBICA J，et al.Twelve-month results of a paclitaxel releasing balloon in patients presenting with in-stent restenosis First-in-Man（PEPPER）trial［J］.Cardiovasc Revasc Med，2012，13（5）：260-264.

［65］ WAKSMAN R，PAKALA R.Drug-eluting balloon：the comeback kid?［J］.Circ Cardiovasc Interv，2009，2（4）：352-358.

［66］ MEHILLI J，DIBRA A，KASTRATI A，et al.Randomized trial of paclitaxel-and sirolimus-eluting stents in small coronary vessels［J］.Eur Heart J，2006，27（3）：260-266.

［67］ MAURI L，ORAV E J，KUNTZ R E.Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison［J］.Circulation，2005，111（25）：3435-3442.

［68］ BIONDI-ZOCCAI G，MORETTI C，ABBATE A，et al.Percutaneous coronary intervention for small vessel coronary artery disease［J］.Cardiovasc Revasc Med，2010，11（3）：189-198.

［69］ UNVERDORBEN M，KLEBER F X，HEUER H，et al.Treatment of small coronary arteries with a paclitaxel-coated balloon catheter［J］.Clin Res Cardiol，2010，99（3）：165-174.

［70］ CORTESE B，MICHELI A，PICCHI A，et al.Paclitaxel-coated balloon versus drugeluting stent during PCI of small coronary vessels，a prospective randomised clinical trial.The PICCOLETO study［J］.Heart，2010，96（16）：1291-1296.

［71］ DIBRA A，KASTRATI A，MEHILLI J，et al.Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients［J］.N Engl J Med，2005，353（7）：663-670.

［72］ HONG S J，KIM M H，AHN T H，et al.Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetes［J］.Heart，2006，92（8）：1119-1124.

［73］ KORNOWSKI R，MINTZ G S，KENT K M，et al.Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia.A serial intravascular ultrasound study［J］.Circulation，1997，95（6）：1366-1369.

［74］ ALI R M，DEGENHARDT R，ZAMBAHARI R，et al.Paclitaxel-eluting balloon angioplasty and cobalt-chromium stents versus conventional angioplasty and paclitaxeleluting stents in the treatment of native coronary artery stenoses in patients with diabetes mellitus［J］.EuroIntervention，2011，7 Suppl K：K83-K92.

［75］ HILDICK-SMITH D，DE BELDER A J，COOTER N，et al.Randomized trial of simple versus complex drug-eluting stenting for bifurcation lesions：the British Bifurcation Coronary Study：old，new，and evolving strategies［J］.Circulation，2010，121（10）：1235-1243.

［76］ BRAR S S，GRAY W A，DANGAS G，et al.Bifurcation stenting with drug-eluting stents：a systematic review and meta-analysis of randomized trials［J］.EuroIntervention，2009，5（4）：475-484.

［77］ FANGGIDAY J C，STELLA P R，GUYOMI S H，et al.Safety and efficacy of drug-eluting balloons in percutaneous treatment of bifurcation lesions：the DCBIUT（Drug-Eluting Balloon in Bifurcation Utrecht） registry［J］.Catheter Cardiovasc Interv，2008，71（5）：629-635.

［78］ STELLA P R，BELKACEMI A，DUBOIS C，et al.A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drugeluting stent in bifurcation lesions treated with a single-stenting technique：six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial［J］.Catheter Cardiovasc Interv，2012，80（7）：1138-1146.

［79］ MATHEY D G，WENDIG I，BOXBERGER M，et al.Treatment of bifurcation lesions with a drug-eluting balloon：the PEPCADⅤ（Paclitaxel Eluting PTCA Balloon in Coronary Artery Disease） trial［J］.EuroIntervention，2011，7 Suppl K：K61-K65.

［80］ SGUEGLIA G A，TODARO D，BISCIGLIA A，et al.Kissing inflation is feasible with all second-generation drug-eluting balloons［J］.Cardiovasc Revasc Med，2011，12（5）：280-285.

［81］ FINN A V，KOLODGIE F D，HARNEK J，et al.Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus-or paclitaxel-eluting stents［J］.Circulation，2005，112（2）：270-278.

［82］ LIM S Y，JEONG M H，HONG S J，et al.Inflammation and delayed endothelization with overlapping drug-eluting stents in a porcine model of in-stent restenosis［J］.Circ J，2008，72（3）：463-468.

［83］ HER S H，YOO K D，PARK C S，et al.Long-term clinical outcomes of overlapping heterogeneous drug-eluting stents compared with homogeneous drug-eluting stents［J］.Heart，2011，97（18）：1501-1506.

［84］ KANG W C，OH K J，HAN S H，et al.Angiographic and intravascular ultrasound study of the effects of overlapping sirolimus-and paclitaxel-eluting stents：comparison with same drug-eluting overlapping stents［J］.Int J Cardiol，2007，123（1）：12-17.

［85］ RÄBER L，JÜNI P，LÖFFEL L，et al.Impact of stent overlap on angiographic and longterm clinical outcome in patients undergoing drug-eluting stent implantation［J］.J Am Coll Cardiol，2010，55（12）：1178-1188.

［86］ HERDEG C，GÖHRING-FRISCHHOLZ K，HAASE K K，et al.Catheter-based delivery of fluid paclitaxel for prevention of restenosis in native coronary artery lesions after stent implantation［J］.Circ Cardiovasc Interv，2009，2（4）：294-301.

［87］ BONAVENTURA K，LEBER A W，SOHNS C，et al.Cost-effectiveness of paclitaxelcoated balloon angioplasty and paclitaxel-eluting stent implantation for treatment of coronary in-stent restenosis in patients with stable coronary artery disease［J］.Clin Res Cardiol，2012，101（7）：573-584.

［88］ CREMERS B，CLEVER Y，SCHAFFNER S，et al.Treatment of coronary in-stent restenosis with a novel paclitaxel urea coated balloon［J］.Minerva Cardioangiol，2010，58（5）：583-588.

［89］ KUFNER S，CASSESE S，VALESKINI M，et al.Long-term efficacy and safety of paclitaxel-eluting balloon for the treatment of drug-eluting stent restenosis：3-year results of a randomized controlled trial［J］.JACC Cardiovasc Interv，2015，8（7）：877-884.

［90］ WINDECKER S，KOLH P，ALFONSO F，et al.2014 ESC/EACTS Guidelines on myocardial revascularization：the Task Force on Myocardial Revascularization of the European Society of Cardiology（ESC） and the European Association for Cardio-Thoracic Surgery（EACTS）.Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions（EAPCI）［J］.Eur Heart J，2014，35（37）：2541-2619.

［91］ ALFONSO F，PÉREZ-VIZCAYNO M J，CÁRDENAS A，et al.A prospective randomized trial of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis of drug-eluting stents：the RIBS Ⅳ randomized clinical trial［J］.J Am Coll Cardiol，2015，66（1）：23-33.

［92］ ALFONSO F，PÉREZ-VIZCAYNO M J，GÓMEZ-RECIO M，et al.Implications of the“watermelon seeding”phenomenon during coronary interventions for in-stent restenosis［J］.Catheter Cardiovasc Interv，2005，66（4）：521-527.

［93］ ALFONSO F，ZUECO J，CEQUIER A，et al.A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis［J］.J Am Coll Cardiol，2003，42（5）：796-805.

［94］ ALFONSO F，MELGARES R，MAINAR V，et al.Therapeutic implications of instent restenosis located at the stent edge.Insights from the restenosis intra-stent balloon angioplasty versus elective stenting （RIBS） randomized trial［J］.Eur Heart J，2004，25（20）：1829-1835.

［95］ SIONTIS G C，STEFANINI G G，MAVRIDIS D，et al.Percutaneous coronary interventional strategies for treatment of in-stent restenosis：a network meta-analysis［J］.Lancet，2015，386（9994）：655-664.

［96］ GIACOPPO D，GARGIULO G，ARUTA P，et al.Treatment strategies for coronary instent restenosis：systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients［J］.BMJ，2015，351 ：h5392.

［97］ GRANADA J F.Drug-Coated Balloons for In-Stent Restenosis：A Fierce Fight for a“Me-Too”Space［J］.JACC Cardiovasc Interv，2018，11（23）：2378-2380.

［98］ CHEN Y，GAO L，QIN Q，et al.Comparison of 2 different drug-coated balloons in instent restenosis：the RESTORE ISR China randomized trial［J］.JACC Cardiovasc Interv，2018，11（23）：2368-2377.

［99］ PALMERINI T，DELLA RIVA D，BIONDI-ZOCCAI G，et al.Mortality following nonemergent，uncomplicated target lesion revascularization after percutaneous coronary intervention：an individual patient data pooled analysis of 21 randomized trials and 32，524 patients［J］.JACC Cardiovasc Interv，2018，11（9）：892-902.

［100］ ALFONSO F，PÉREZ-VIZCAYNO M J，CUESTA J，et al.3-Year Clinical Follow-Up of the RIBS Ⅳ Clinical Trial：a prospective randomized study of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis in coronary arteries previously treated with drug-eluting stents［J］.JACC Cardiovasc Interv，2018，11（10）：981-991.

［101］ HACHINOHE D，KASHIMA Y，HIRATA K，et al.Treatment for in-stent restenosis requiring rotational atherectomy［J］.J Interv Cardiol，2018，31（6）：747-754.